Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INNV
INNV logo

INNV Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.440
Open
7.310
VWAP
7.27
Vol
587.06K
Mkt Cap
998.83M
Low
7.000
Amount
4.27M
EV/EBITDA(TTM)
40.72
Total Shares
135.71M
EV
987.37M
EV/OCF(TTM)
18.83
P/S(TTM)
1.08
InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.
Show More

Events Timeline

(ET)
2026-02-05
08:50:00
InnovAge Meets Colorado Lawmakers to Emphasize Importance of Senior Care
select
2026-02-03 (ET)
2026-02-03
16:50:00
Company Raises EBITDA Guidance to $70M-$75M
select
2026-02-03
16:50:00
InnovAge Reports Q2 Revenue of $239.7M
select
2026-01-29 (ET)
2026-01-29
08:10:00
InnovAge Appoints New Board Members, Expands to 11 Directors
select
2025-12-16 (ET)
2025-12-16
08:10:00
INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System
select
2025-11-03 (ET)
2025-11-03
17:03:24
InnovAge names Paul Taheri as its new chief medical officer.
select
2025-09-23 (ET)
2025-09-23
08:15:14
InnovAge Names Delk as Executive Vice President and Chief Administrative Officer
select

News

seekingalpha
9.5
05-06seekingalpha
InnovAge Reports Q3 Fiscal 2026 Earnings Highlights
  • Financial Performance Boost: InnovAge reported approximately $252 million in total revenue for Q3 FY2026, a 15.5% increase from $218.1 million in Q3 FY2025, yet faced a net loss of $29.9 million, indicating profitability challenges despite revenue growth.
  • Adjusted EBITDA Guidance Raised: The company raised its FY2026 adjusted EBITDA guidance to a range of $85 million to $90 million, reflecting management's confidence in future operational trends, even amidst anticipated pressures on Medicaid rates.
  • Stable Participant Numbers: As of the end of the quarter, InnovAge served approximately 8,050 participants across 20 centers in 6 states, with expectations for participant numbers to range between 7,900 and 8,100 by the end of FY2026, demonstrating market stability.
  • Surge in Administrative Expenses: Corporate general and administrative expenses reached $76.5 million in Q3, a staggering 98.3% increase year-over-year, primarily driven by rising litigation liabilities, which may impact future profitability.
seekingalpha
9.5
05-05seekingalpha
InnovAge Q1 Earnings Report Analysis
  • Disappointing Earnings: InnovAge reported a Q1 GAAP EPS of -$0.22, missing estimates by $0.28, indicating pressure on profitability that may affect investor confidence.
  • Revenue Growth: The company achieved revenue of $251.9 million, a 6.7% year-over-year increase, beating market expectations by $17.6 million, suggesting some growth potential in a competitive market.
  • Increased Pre-Tax Loss: The pre-tax loss was $29.8 million, a significant increase of approximately 169.2% from $11.1 million in the same quarter last year, with the loss before income tax as a percentage of revenue rising to 11.8%, highlighting challenges in cost control.
  • Improved Contribution Margin: The center-level contribution margin reached $61.0 million, up 49.8% year-over-year, representing 24.2% of revenue, an increase of 5.5 percentage points, indicating signs of improvement in core operations that may lay the groundwork for future profitability.
Benzinga
9.5
02-04Benzinga
Cirrus Logic Reports Strong Q3 Earnings, Shares Surge
  • Earnings Beat: Cirrus Logic reported third-quarter earnings of $2.97 per share, surpassing the analyst consensus estimate of $2.44 per share, indicating a significant improvement in profitability and boosting investor confidence.
  • Sales Growth: The company achieved quarterly sales of $580.620 million, exceeding the analyst consensus estimate of $533.890 million, demonstrating strong market demand and driving sustained performance growth.
  • Stock Surge: Following the positive earnings report, Cirrus Logic's shares jumped 7.6% to $134.10 on Wednesday, reflecting market optimism regarding the company's future growth potential.
  • Optimistic Guidance: Cirrus Logic provided fourth-quarter sales guidance that is expected to exceed market estimates, further solidifying its competitive position in the semiconductor industry.
seekingalpha
9.5
02-04seekingalpha
InnovAge Reports Strong Q2 2026 Earnings with Raised Guidance
  • Strong Financial Performance: InnovAge reported total revenues of $239.7 million for Q2, reflecting a 14.7% year-over-year increase, with a center-level contribution margin of $52.8 million and adjusted EBITDA of $22.2 million, achieving a 9.2% EBITDA margin for the first time, indicating sustained operational and financial execution improvements.
  • Improved Medicaid Environment: The company made progress in Medicaid eligibility and redeterminations, enhancing timeliness and accuracy, reducing reserves, and reinstating coverage for several participants, which is expected to further enhance participant experience and revenue.
  • Raised Full-Year Guidance: InnovAge raised its fiscal 2026 full-year guidance, now expecting member months between 92,900 and 95,700, total revenue between $925 million and $950 million, and adjusted EBITDA between $70 million and $75 million, reflecting ongoing operational improvements and better-than-expected Medicaid rates.
  • Governance Changes: Tom Scully returned as Chairman of the Board, with two board members rejoining, and management expressed gratitude for former leader Jim Carlson's contributions, demonstrating stability in governance and confidence in future growth.
seekingalpha
9.5
02-03seekingalpha
InnovAge Q2 Earnings Beat Expectations with Raised FY2026 Guidance
  • Strong Earnings Report: InnovAge reported a GAAP EPS of $0.08 for Q2, beating expectations by $0.04, indicating sustained improvement in profitability that is likely to positively impact stock performance.
  • Significant Revenue Growth: The company achieved revenues of $239.71 million, a 14.7% year-over-year increase, surpassing market expectations by $11.41 million, reflecting strong business expansion and market demand.
  • Raised Financial Guidance: InnovAge has raised its full fiscal year 2026 financial guidance, projecting total revenues between $925 million and $950 million, with adjusted EBITDA expected to be between $70 million and $75 million, demonstrating confidence in future growth.
  • Stable Membership Growth: While the ending census forecast remains unchanged, total member months are expected to reach between 92,900 and 95,700, indicating stable growth in the customer base and enhancing market competitiveness.
Newsfilter
1.0
2025-12-30Newsfilter
InnovAge CEO Patrick Blair to Present at 2026 J.P. Morgan Healthcare Conference
  • Executive Presentation: InnovAge CEO Patrick Blair is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, showcasing the company's leadership in providing comprehensive healthcare services to frail seniors, which is expected to attract investor interest.
  • Market Leadership: As of September 30, 2025, InnovAge serves approximately 7,890 participants across 20 centers in six states, indicating its significant impact in managing high-cost healthcare, thereby further solidifying its market position.
  • Innovative Care Model: InnovAge's PACE model aims to enhance the ability of seniors to live independently while reducing over-utilization of high-cost care settings, reflecting the company's commitment to improving care quality for older adults, which may attract more support from government payors.
  • Investor Relations: The live webcast of the conference will provide real-time information to investors, enhancing interaction between the company and its investors, thereby increasing transparency and trust in the healthcare sector.

Valuation Metrics

The current forward P/E ratio for InnovAge Holding Corp (INNV.O) is 13.66, compared to its 5-year average forward P/E of -53.61. For a more detailed relative valuation and DCF analysis to assess InnovAge Holding Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-53.61
Current PE
13.66
Overvalued PE
1054.60
Undervalued PE
-1161.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-3.28
Current EV/EBITDA
-10.04
Overvalued EV/EBITDA
186.84
Undervalued EV/EBITDA
-193.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.15
Current PS
0.97
Overvalued PS
1.91
Undervalued PS
0.40

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks that will explode in next 30 days
Intellectia · 640 candidates
Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5, PriceAboveMA20Month Price Change Pct: >= $0.00One Month Rise Prob: >= 70One Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PRCH logo
PRCH
Porch Group Inc
1.23B
ROMA logo
ROMA
Roma Green Finance Ltd
396.70M
MCBS logo
MCBS
Metrocity Bankshares Inc
921.13M
UA logo
UA
Under Armour Inc
2.59B
INNV logo
INNV
InnovAge Holding Corp
1.08B
DOCN logo
DOCN
DigitalOcean Holdings Inc
15.94B
stock bullish for a month
Intellectia · 644 candidates
Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $0.00Ema 20: >= 0Ema 60: >= 0One Month Rise Prob: >= 70One Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
WOK logo
WOK
WORK Medical Technology Group Ltd
2.40M
SABS logo
SABS
SAB Biotherapeutics Inc
258.61M
GIII logo
GIII
G-III Apparel Group Ltd
1.31B
IRIX logo
IRIX
IRIDEX Corp
18.27M
CCO logo
CCO
Clear Channel Outdoor Holdings Inc
1.19B
VTMX logo
VTMX
Vesta Real Estate Corporation SAB de CV
3.03B

Whales Holding INNV

C
Coliseum Capital Management, LLC
Holding
INNV
-0.38%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is InnovAge Holding Corp (INNV) stock price today?

The current price of INNV is 7.36 USD — it has decreased -2.77

What is InnovAge Holding Corp (INNV)'s business?

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

What is the price predicton of INNV Stock?

Wall Street analysts forecast INNV stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is InnovAge Holding Corp (INNV)'s revenue for the last quarter?

InnovAge Holding Corp revenue for the last quarter amounts to 251.94M USD, increased 15.49

What is InnovAge Holding Corp (INNV)'s earnings per share (EPS) for the last quarter?

InnovAge Holding Corp. EPS for the last quarter amounts to -0.22 USD, increased 175.00

How many employees does InnovAge Holding Corp (INNV). have?

InnovAge Holding Corp (INNV) has 2440 emplpoyees as of May 12 2026.

What is InnovAge Holding Corp (INNV) market cap?

Today INNV has the market capitalization of 998.83M USD.